This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
PetMed (PETS) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -90.48% and 7.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Coupang, Inc. (CPNG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Coupang, Inc. (CPNG) closed the most recent trading day at $16.51, moving +1.98% from the previous trading session.
Coupang, Inc. (CPNG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Coupang, Inc. (CPNG) closed at $16.48 in the latest trading session, marking a -1.38% move from the prior day.
Coupang, Inc. (CPNG) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Coupang, Inc. (CPNG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Coupang, Inc. (CPNG) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Coupang, Inc. (CPNG) closed at $16.69, marking no change from the previous day.
Coupang, Inc. (CPNG) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
In the latest trading session, Coupang, Inc. (CPNG) closed at $17, marking no change from the previous day.
Coupang, Inc. (CPNG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Coupang, Inc. (CPNG) closed at $16.91, marking a -1.97% move from the previous day.
Coupang, Inc. (CPNG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Coupang, Inc. (CPNG) closed at $15.81 in the latest trading session, marking a +1.15% move from the prior day.
Has Coupang (CPNG) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Here is how Coupang, Inc. (CPNG) and Dillard's (DDS) have performed compared to their sector so far this year.
The Zacks Analyst Blog Highlights JD.com, Sigma Lithium, Dr. Reddys Laboratories, MakeMyTrip and Coupang
by Zacks Equity Research
JD.com, Sigma Lithium, Dr. Reddys Laboratories, MakeMyTrip and Coupang are part of the Zacks top Analyst Blog.
5 Best Emerging Markets Stocks to Buy for 2023
by Urmimala Biswas
Here are five emerging market stocks, JD, SGML, RDY, MMYT and CPNG that are expected to gain enormously in 2023, capitalizing on their growth prospects.
Down 18.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Coupang, Inc. (CPNG)
by Zacks Equity Research
Coupang, Inc. (CPNG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Use this First Profit Screen to Find Great Stocks to Buy in December
by Benjamin Rains
Today, we utilized our Zacks 'First Profit' screen to identify potentially winning stocks that turned things around recently and might continue to improve in December and beyond.
Wall Street Analysts Believe Coupang, Inc. (CPNG) Could Rally 32%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 31.7% in Coupang, Inc. (CPNG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Coupang, Inc. (CPNG) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Coupang, Inc. (CPNG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Coupang, Inc. (CPNG) Q3 Earnings Beat Estimates
by Zacks Equity Research
Coupang, Inc. (CPNG) delivered earnings and revenue surprises of 266.67% and 1.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Coupang (CPNG) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Coupang's (CPNG) third-quarter results are expected to reflect strength in its e-commerce business and the momentum across Rocket Delivery.
Zacks.com featured highlights include Vital Farms, Coupang and Webster Financial
by Zacks Equity Research
Vital Farms, Coupang and Webster Financial are part of the Zacks Screen of the Week article.
Buy 3 of the Best Stocks for Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks like Vital Farms (VITL), Coupang (CPNG) and Webster Financial (WBS) at the moment for superb earnings acceleration.
Coupang, Inc. (CPNG) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
Coupang, Inc. (CPNG) closed at $17.24 in the latest trading session, marking a -0.17% move from the prior day.
How Much Upside is Left in Coupang, Inc. (CPNG)? Wall Street Analysts Think 31%
by Zacks Equity Research
The mean of analysts' price targets for Coupang, Inc. (CPNG) points to a 31.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Coupang, Inc. (CPNG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Coupang, Inc. (CPNG) closed at $16.49, marking a +1.98% move from the previous day.
Zacks Industry Outlook Highlights Coupang, JD.com, Jumia Technologies and Amazon
by Zacks Equity Research
Coupang, JD.com, Jumia Technologies and Amazon have been highlighted in this Industry Outlook article.
3 Ecommerce Picks as Industry Gears Up for Holiday Season
by Sejuti Banerjea
Holiday sales will boost near term performance for most players in the Electronic Commerce industry, although valuation remains an issue, especially considering the deteriorating outlook in 2023.
Zacks.com featured highlights Coupang, Nabors Industries and Bank of N.T. Butterfield & Son
by Zacks Equity Research
Coupang, Nabors Industries and Bank of N.T. Butterfield & Son have been highlighted in this Screen of The Week article.